Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
This fund aims to deliver long-term capital growth by investing in equities of biotechnology companies globally. It allocates at least two-thirds of assets to equity securities of biotechnology companies focused on drug discovery, development, and life sciences innovation worldwide. The strategy employs Pictet's specialist biotech research focused on identifying companies with promising drug pipelines, innovative platforms, and attractive growth prospects in biotech innovation. Through dedicated biotechnology equity investment, the fund provides focused biotech sector exposure, appropriate for thematic investors seeking biotechnology participation with acceptance of sector concentration and binary clinical risks. more
| Time Frame | Absolute | Annualised |
|---|---|---|
| 1-Year Return | +61.77% | +61.77% |
| 3-Year Return | +97.12% | +25.36% |
| 5-Year Return | +54.49% | +9.08% |
| 10-Year Return | +158.79% | +9.97% |
| All Time Return | +2,245.66% | +10.80% |
Link copied